Yüklüyor......

Maintenance of Androgen Receptor Inactivation by S-nitrosylation

Anti-androgens target ligand binding domain of AR and are used as frontline therapeutics to treat patients diagnosed with locally advanced and metastatic prostate cancer. Although initially beneficial as judged with actual tumor mass shrinkage, this therapy invariably fails and the cancer reappears...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Qin, Yu, Dey, Anindya, Purayil, Hamsa Thayele, Daaka, Yehia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3861894/
https://ncbi.nlm.nih.gov/pubmed/24121486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!